McLaren HVC Program

High value care Program Leadership

High Value Care Corporate Steering Committee

Chair

- Dr. Michael McKenna, EVP / CMO MHC

Members

- Dr. Dennis Spender, CMO McLaren Laboratory
- Dr. Brad Ropp, CMO McLaren Medical Group
- Dr. Sara Liter-Kuester, Cerner Project Physician Lead
- Dr. Robert Flora, Chief Academic Officer MHC
- Dr. Binesh Patel, CMO McLaren Flint
- Dr. Kevin Carter, Chief of Staff McLaren Lapeer
- Dr. Michael Ziccardi, Medical Director McLaren Physician Practice
- Dr. Erlene Seymour, Karmanos Cancer Center
- Dr. Asif Ishaque, Chair, PMC ACO
- Dr. Tim Hannon, CEO Healthcare Forward
- Chandan Gupte, VP Clinical Excellence MHC
- Danette Hayman, Director Corporate Quality MHC
- Don Henderson, VP McLaren Laboratory
- Dr. Carlos Rios-Bedoya, Corporate Director of Scholarly Inquiry
- Bernie Adams, SSBB, Director of Performance Improvement Education

Repetitive Testing Task Force

Co-chairs

- Dr. Neil Caliman, Pathology Medical Director Greater Lansing
- Dr. Anil Kumar, Critical Care Medical Director Greater Lansing

Members

- Dr. Andrew McDonagh, CMO Northern
- Dr. Binesh Patel, CMO Flint
- Dr. Tim Hannon, CEO Healthcare Forward
- Dr. Heather Signorelli, Medical Director Healthcare Forward
- Chandan Gupte, VP Clinical Excellence and Research
- Danette Hayman, Corporate Director of Quality
- Don Henderson, VP McLaren Laboratory

Reference Lab Testing Task Force

Co-chairs

- Dr. Shane Starr, Pathology Medical Director McLaren Bay Region
- Dr. Erlene Seymour, Oncologist Karmanos Cancer Center

Members

- Dr. Paul Swerdlow, Hematologist Karmanos Cancer Center
- Dr. Tim Hannon, CEO Healthcare Forward
- Dr. Heather Signorelli, Medical Director Healthcare Forward
- Chandan Gupte, VP Clinical Excellence and Research
- Danette Hayman, Corporate Director of Quality
- Don Henderson, VP McLaren Laboratory

Antimicrobial Stewardship Task Force

Members

Dr. Jon Sangeorzan, Infectious Disease McLaren Northern
Dr. Dennis Spender, CMO McLaren Labs
Dr. Aaron Goldfarb, Pathology Medical Director McLaren Port Huron
Dr. Binesh Patel, CMO McLaren Flint
Dr. Tim Hannon, CEO Healthcare Forward
Dr. Heather Signorelli, Medical Director Healthcare Forward
Brian Hatcher, Microbiology Director McLaren Labs
Lisa Engles, Epidemiology Coordinator Karmanos Cancer Center
Karolina Kaser, Infection Preventionist McLaren Oakland

Imaging Appropriate Use Criteria Task Force

Co-chairs

Dr. Kevin Carter, Radiology Medical Director McLaren Oakland
Mark Gray, Corporate Director Information Technology

Members

Dr. Sara Liter-Kuester, ONE McLaren Physician Lead
Dr. Brad Ropp, CMO McLaren Medical Group
Dr. Michael Ziccardi, CMO McLaren Physician Partners
Dr. Tressa Gardner, Regional Medical Director American Physician Partners
Dr. Tim Hannon, CEO Healthcare Forward
Chandan Gupte, VP Clinical Excellence and Research
Danette Hayman, Corporate Director of Quality
Janelle Spann, Director Imaging Services
Kimberly Segal, Corporate Manager Revenue Integrity
Melissa Benchley, Regional Director Patient Access, McLaren Northern Michigan
Kim Chaltry, Director of Medical Imaging Services and Radiation Oncology, McLaren Port Huron
Brina Rolison, Quality Improvement Analyst

High Sensitivity Troponin Working Group

Members

Dr. Dennis Spender, CMO McLaren Labs
Dr. Timothy Logan, Cardiologist, Macomb
Dr. Nicolas Mouawad, Bay Heart & Vascular
Dr. Tressa Gardner, Executive Medical Director, American Physician Partners
Dr. Raymond Rudoni, Emergency Medicine Medical Director, McLaren Flint
Dr. Bob Flora, Chief Academic Officer MHC
Dr. Tim Hannon, CEO Healthcare Forward
Betsy Felton, Corporate Director of Cardiovascular Service Line
Chandan Gupte, VP Clinical Excellence MHC
Danette Hayman, Director Corporate Quality MHC
Brina Anderson, Quality Improvement Analyst MHC

Report abuse